Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$15.42 - $27.01 $967,188 - $1.69 Million
-62,723 Reduced 61.71%
38,914 $885,000
Q2 2022

Aug 15, 2022

SELL
$13.27 - $25.5 $807,506 - $1.55 Million
-60,852 Reduced 37.45%
101,637 $1.83 Million
Q1 2022

May 16, 2022

BUY
$13.42 - $29.73 $872,501 - $1.93 Million
65,015 Added 66.7%
162,489 $4.34 Million
Q4 2021

Feb 14, 2022

BUY
$27.59 - $66.39 $2.69 Million - $6.47 Million
97,474 New
97,474 $2.86 Million
Q1 2021

May 17, 2021

SELL
$71.56 - $121.23 $645,757 - $1.09 Million
-9,024 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$47.41 - $115.03 $990,774 - $2.4 Million
-20,898 Reduced 69.84%
9,024 $797,000
Q3 2020

Nov 16, 2020

BUY
$43.0 - $84.01 $1.29 Million - $2.51 Million
29,922 New
29,922 $2.21 Million

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $517M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.